R1 Leads Busy Fundraising Day With $77.5M Series A Raise for Kidney Disease

By /

Alongside R1 Therapeutics, Mestag Therapeutics and iDEL Therapeutics also brought in money on Tuesday, helping to push their respective cancer portfolios forward.

Scroll to Top